Publication, Part of Health and Care of People with Learning Disabilities
Health and Care of People with Learning Disabilities Experimental Statistics 2019 to 2020
Experimental statistics, Other reports and statistics, Official statistics in development
ADHD, Autism and Epilepsy
ADHD
The percentage of patients with a learning disability, who also have a diagnosis of ADHD is significantly greater than the percentage of the population who have a diagnosis of ADHD but do not have a learning disability. The percentage of patients who have a diagnosis of ADHD has significantly increased in both populations each year from 4.7% in 2015-16 to 6.5% in 2019-20 for patients with a learning disability and 0.4% in 2015-16 to 0.6% in 2019-20 for patients without a learning disability.
ADHD with melatonin
Each year between 2015-16 and 2019-20, a significantly larger percentage of patients with a learning disability, who also have a diagnosis of ADHD, were treated with melatonin than the population of patients who have a diagnosis of ADHD who don’t have a learning disability. This ranges from a difference of 3.3 percentage points in 2015-16 to 4.2 percentage points in 2019-20.
Autism
In 2019-20, the percentage of patients without a learning disability who had a diagnosis of autism was significantly lower (0.7%) than in patients with a learning disability (24.8%). This is also a significant increase in the percentage of patients with a learning disability who also had a diagnosis of autism from 18.4% in 2015-16.
In 2015-16 patients with a learning disability were 27 times more likely to be diagnosed with autism than those without a learning disability this fell to 23 times more likely in 2019-20.
Epilepsy and currently on drug treatment for epilepsy
Each year between 2015-16 and 2019-20, a significantly larger percentage of patients with a learning disability, and who have a diagnosis of epilepsy, are currently on drug treatment for epilepsy than the population of patients who have a diagnosis of epilepsy and are currently on drug treatment for epilepsy who don’t have a learning disability. This ranges from a difference of 16.7 percentage points in 2015-16 to 16.1 percentage points in 2019-20.
Epilepsy, currently on drug treatment for epilepsy and have a seizure frequency record at the end of the reporting period
Each year between 2015-16 and 2019-20, a significantly larger percentage of patients with a learning disability, who have a diagnosis of epilepsy and are currently on drug treatment for epilepsy have a record of seizure frequency in the 12 months up to and including the end of the reporting period compared to patients without a learning disability.
The percentage of patients with a learning disability, who have a diagnosis of epilepsy and are currently on drug treatment for epilepsy and have a record of seizure frequency has increased from 23.5% in 2015-16 to 30.4% in 2018-19 with a small decrease to 29.6% in 2019-20. The cohort of patients without a learning disability decreased steadily from 13.9% in 2015-16 to 9.0% in 2019-20.
Epilepsy, currently on drug treatment for epilepsy and have a seizure frequency record at the end of the reporting period and those with who have been seizure free over the same period
Each year between 2015-16 and 2019-20, a significantly smaller percentage of patients with a learning disability, who have a diagnosis of epilepsy and are currently on drug treatment for epilepsy have a record of seizure frequency who have been seizure-free in the 12 months up to and including the end of the reporting period compared to patients without a learning disability.
Last edited: 6 March 2023 9:37 am